Tag: Immune Disorders
ACR: Inebilizumab Reduces Risk for Flares in IgG4-Related Disease
Flare-free, treatment-free complete remission and flare-free, glucocorticoid-free complete remission improved with inebilizumab
Systemic Immune-Inflammation Index Tied to Mortality in CKD
Association most pronounced for those older than 60 years and those with diabetes
Childhood Obesity Tied to Pediatric Immune-Mediated Skin Diseases
Weight gain may increase atopic dermatitis risk, while weight loss may lower the risk
Algorithm From EHR Can ID Common Variable Immunodeficiency Disease
74 percent of the top 100 patients ranked by PheNet were highly probable to have CVID
EEG Most Beneficial Tool for Managing CAR T-Cell-Related Neurotoxicity
Therapeutic modification seen for 16 percent of patients with immune effector cell-associated neurotoxicity syndrome undergoing EEG
Risk for Autoimmune Inflammatory Rheumatic Disease Increased After SARS-CoV-2
Increased risk seen for incident AIRD for patients with SARS-CoV-2, with higher risk seen after more severe acute COVID-19
CAR T-Cell Therapy Feasible, Safe for Autoimmune Diseases
Beneficial outcomes seen for patients with systemic lupus erythematosus, idiopathic inflammatory myositis, systemic sclerosis
Incidence of Autoimmune Disease Increased After Surgical Remission of Cushing
Incidence of new-onset autoimmune disease higher compared with those with nonfunctioning pituitary adenomas
Link Between Inflammatory Disease, Adverse Pregnancy Outcomes Varies
Patients with IMIDs had increased risk for PTB, LBW, SGA, C-section overall, but variation seen by disease, comorbidities
Prolonged SARS-CoV-2 Risk Varies Across Immunosuppressive Conditions
Severely immunocompromised individuals had greater SARS-CoV-2 evolution, higher risk for developing resistance against therapeutic mAbs
